Zhang, Mingzi
Liu, Jinlong
Zhang, Haibo
Verrelli, David I.
Wang, Qian
Hu, Liwei
Li, Yujie
Ohta, Makoto
Liu, Jinfen
Funding for this research was provided by:
National Natural Science Foundation of China (81970439)
National Natural Science Foundation of China (81501558)
International Science and Technology Cooperation Programme (18410721400)
Shanghai Science and Technology Committee (17441903300)
Shanghai Science and Technology Committee (17DZ2253100)
Article History
Received: 7 July 2020
Accepted: 2 December 2020
First Online: 4 March 2021
Compliance with Ethical Standards
:
: We have not identified any conflict of interest to be disclosed regarding publication of this manuscript. Dr. Zhao Xi is employed by Fosun Co., Ltd. (Shanghai, China). No industry funding was received for this study. Authors with no relation to the pharmaceutical industry had control of the data and information that might have presented a conflict of interest.
: This study was approved by the institutional review board of Shanghai Children’s Medical Centre (No. SCMCIRB-Y2019044).
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients (or their guardians) for being included in the study.